chr17-15239575-G-A

Variant summary

Our verdict is Likely pathogenic.
+9 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 9 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_ModerateO3_ModerateO5_SupportingO6_SupportingO7_ModerateO8_Supporting

The NM_000304.4(PMP22):c.215C>T (p.Ser72Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The gene PMP22 is a tumor suppressor gene (CancerMine: 1 TSG, 2 oncogene citations). The gene PMP22 is a known oncogene (CancerMine: 1 TSG, 2 oncogene citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.82). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.S72P: Pathogenic (ClinVar VariationId 637384, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S72= (synonymous): Likely_benign (ClinVar VariationId 1186631, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 33)

Consequence

PMP22
NM_000304.4 missense

Scores

14
5

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 9.82

Publications

24 publications found
Variant links:
Genes affected
PMP22 (HGNC:9118): (peripheral myelin protein 22) This gene encodes an integral membrane protein that is a major component of myelin in the peripheral nervous system. Studies suggest two alternately used promoters drive tissue-specific expression. Various mutations of this gene are causes of Charcot-Marie-Tooth disease Type IA, Dejerine-Sottas syndrome, and hereditary neuropathy with liability to pressure palsies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
PMP22 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 1A
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hereditary neuropathy with liability to pressure palsies
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Orphanet
  • Charcot-Marie-Tooth disease type 1E
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000304.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 9 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP ★★+ — Moderate (O1); O1 contributing sources (2.0 pts): ClinVar germline P/LP in TSG (★★)
O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])
O5Same location/impact as known oncogenic
Different AA at same residue with oncogenic evidence (or germline P/LP in TSG), or same AA change SCI Tier II Potential — Supporting (O5); ClinVar same-AA oncogenic/T1: false | ClinVar same-AA SCI tier: — | CGI same-AA oncogenic: false | TSG: true | ClinVar same-AA germline P/LP: false | CIViC LOF: false | ClinVar diff-AA oncogenic: false | ClinVar diff-AA germline P/LP: true
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 46 pathogenic, 7 benign (OR vs. background: 31.0).; ±8 AA neighbourhood: 11 pathogenic, 0 benign (OR vs. background: 115.0); Variant does not impact splicing — splice-hotspot path not applicable
O8Missense constraint in gene or region
Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 0.70 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000304.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

PMP22 NM_000304.4
MANE Select
HGVSc / HGVSpc.215C>Tp.Ser72Leu
Exon rankExon 4 of 5
missense
Prot: NP_000295.1UniProt: Q01453Q6FH25
PMP22 NM_001281455.2
HGVSc / HGVSpc.215C>Tp.Ser72Leu
Exon rankExon 4 of 5
missense
Prot: NP_001268384.1UniProt: Q6FH25Q01453
PMP22 NM_001281456.2
HGVSc / HGVSpc.215C>Tp.Ser72Leu
Exon rankExon 4 of 5
missense
Prot: NP_001268385.1UniProt: Q01453Q6FH25

Ensembl Transcripts

PMP22 ENST00000312280.9
TSL:1MANE Select
HGVSc / HGVSpc.215C>Tp.Ser72Leu
Exon rankExon 4 of 5
missense
Prot: ENSP00000308937.3UniProt: Q01453
PMP22 ENST00000494511.7
TSL:1
HGVSc / HGVSpc.11C>Tp.Ser4Leu
Exon rankExon 2 of 3
missense
Prot: ENSP00000462782.2UniProt: J3KT36
PMP22 ENST00000395938.7
TSL:1
HGVSc / HGVSpc.204C>Tp.Val68Val
Exon rankExon 4 of 5
synonymous
Prot: ENSP00000379269.3UniProt: A0A6Q8PF08

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:33
GnomAD4 genome
Cov:33
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:23454
Showing 4 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
not provided (3)
1
-
-
Charcot-Marie-Tooth disease, type I (1)
1
-
-
Charcot-Marie-Tooth disease, type IA (1)
1
-
-
DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
PMP22-related disorder (1)

Computational Scores

AlphaGenome AVI
Pathogenic30
AlphaMissense
Pathogenic0.97
BayesDel_addAF
Pathogenic0.49D
BayesDel_noAF
Pathogenic0.46
CADD
Pathogenic33
DANN
Uncertain0.99
DEOGEN2
Pathogenic0.97D
Eigen
Pathogenic0.97
Eigen_PC
Pathogenic0.94
FATHMM_MKL
Pathogenic1.0D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-7.3
GPN-Star score
N/A7.3
LIST_S2
Uncertain0.96D
M_CAP
Pathogenic0.36D
MetaRNN
Pathogenic0.98D
MetaSVM
Pathogenic0.92D
Mutation Taster
N/A1/99disease causing (ClinVar)
MutationAssessor
Pathogenic3.2M
PhyloP100
Pathogenic9.8
popEVE
Benign-4.1
PrimateAI
Uncertain0.68T
PROVEAN
Pathogenic-4.8D
REVEL
Pathogenic0.89
Sift
Uncertain0.0020D
Sift4G
Uncertain0.0030D
Varity_R
N/A0.71
VESM-3B
Benign-14
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.